Pharmaceutical Preparations
397 stocks in Healthcare & Pharma · SIC 2834.
Company snapshot 2026-10-09 · Calculated market cap as of 2026-10-02 · USD
| Ticker | Company | Market Cap | Revenue (TTM) | Net Income (TTM) |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.08T | $79.67BTTM ended 2026-06-30 | $26.71BTTM ended 2026-06-30 |
| JNJ | JOHNSON & JOHNSON | $623.34B | $97.93BTTM ended 2026-06-28 | $21.04BTTM ended 2026-06-28 |
| ABBV | AbbVie Inc. | $459.33B | $64.39BTTM ended 2026-06-30 | $6.31BTTM ended 2026-06-30 |
| MRK | Merck & Co., Inc. | $354.80B | $66.57BTTM ended 2026-06-30 | $3.17BTTM ended 2026-06-30 |
| ABT | ABBOTT LABORATORIES | $167.31B | $45.13BTTM ended 2026-03-31 | $6.28BTTM ended 2026-03-31 |
| PFE | PFIZER INC | $160.27B | $63.70BTTM ended 2026-06-28 | $4.33BTTM ended 2026-06-28 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $128.44B | $12.59BTTM ended 2026-06-30 | $4.41BTTM ended 2026-06-30 |
| BMY | BRISTOL MYERS SQUIBB CO | $125.55B | $49.19BTTM ended 2026-06-30 | $9.28BTTM ended 2026-06-30 |
| REGN | REGENERON PHARMACEUTICALS, INC. | $75.65B | $15.53BTTM ended 2026-06-30 | $4.33BTTM ended 2026-06-30 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $30.93B | $4.80BTTM ended 2026-06-30 | $774.71MTTM ended 2026-06-30 |
| ZTS | Zoetis Inc. | $28.55B | $9.53BTTM ended 2026-06-30 | $2.64BTTM ended 2026-06-30 |
| ROIV | Roivant Sciences Ltd. | $25.64B | $7.53MTTM ended 2026-06-30 | −$266.25MTTM ended 2026-06-30 |
| UTHR | UNITED THERAPEUTICS Corp | $24.51B | $3.15BTTM ended 2026-06-30 | $1.31BTTM ended 2026-06-30 |
| INSM | INSMED Inc | $23.71B | $1.14BTTM ended 2026-06-30 | −$875.31MTTM ended 2026-06-30 |
| VTRS | Viatris Inc | $20.05B | $14.69BTTM ended 2026-06-30 | −$3.51BTTM ended 2025-12-31 |
| JAZZ | Jazz Pharmaceuticals plc | $15.13B | $4.60BTTM ended 2026-06-30 | $940.75MTTM ended 2026-06-30 |
| SMMT | Summit Therapeutics Inc. | $13.31B | — | −$856.09MTTM ended 2026-06-30 |
| BBIO | BridgeBio Pharma, Inc. | $13.08B | $713.07MTTM ended 2026-06-30 | −$702.02MTTM ended 2026-06-30 |
| CORT | CORCEPT THERAPEUTICS INC | $12.33B | $830.81MTTM ended 2026-06-30 | $55.18MTTM ended 2026-06-30 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $11.55B | $1.28BTTM ended 2026-06-30 | −$325.10MTTM ended 2026-06-30 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.31B | $3.41BTTM ended 2026-06-30 | $72.97MTTM ended 2026-06-30 |
| ELAN | Elanco Animal Health Inc | $10.88B | $5.02BTTM ended 2026-06-30 | −$199.00MTTM ended 2026-06-30 |
| AXSM | Axsome Therapeutics, Inc. | $9.54B | $776.57MTTM ended 2026-06-30 | −$191.64MTTM ended 2026-06-30 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $9.15B | $669.50MTTM ended 2026-06-30 | −$319.95MTTM ended 2026-06-30 |
| CYTK | CYTOKINETICS INC | $9.12B | $67.67MTTM ended 2026-06-30 | −$894.00MTTM ended 2026-06-30 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.01B | $42.16MTTM ended 2026-06-30 | −$501.61MTTM ended 2026-06-30 |
| PTGX | Protagonist Therapeutics, Inc | $9.01B | $74.06MTTM ended 2026-03-31 | $82.91MTTM ended 2026-06-30 |
| TGTX | TG THERAPEUTICS, INC. | $8.21B | $799.54MTTM ended 2026-06-30 | $441.49MTTM ended 2026-06-30 |
| PRAX | Praxis Precision Medicines, Inc. | $8.01B | $0.00TTM ended 2025-12-31 | −$339.13MTTM ended 2026-06-30 |
| SYRE | Spyre Therapeutics, Inc. | $7.93B | $0.00TTM ended 2025-12-31 | −$178.92MTTM ended 2026-06-30 |
| IONS | IONIS PHARMACEUTICALS INC | $7.31B | $874.09MTTM ended 2026-06-30 | −$565.17MTTM ended 2026-06-30 |
| ALKS | Alkermes plc. | $6.80B | $1.67BTTM ended 2026-06-30 | $66.12MTTM ended 2026-06-30 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | $6.43B | $239.92MTTM ended 2026-06-30 | −$205.35MTTM ended 2026-06-30 |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.41B | $3.12BTTM ended 2026-06-30 | $157.36MTTM ended 2026-06-30 |
| LGND | LIGAND PHARMACEUTICALS INC | $6.04B | $290.54MTTM ended 2026-06-30 | $197.22MTTM ended 2026-06-30 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $5.87B | $754.04MTTM ended 2026-03-31 | $73.06MTTM ended 2026-03-31 |
| ORKA | Oruka Therapeutics, Inc. | $5.52B | — | −$132.89MTTM ended 2026-06-30 |
| COGT | Cogent Biosciences, Inc. | $5.48B | — | −$377.18MTTM ended 2026-06-30 |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.45B | $618.07MTTM ended 2026-06-30 | −$860.21MTTM ended 2026-06-30 |
| TVTX | Travere Therapeutics, Inc. | $5.36B | $591.33MTTM ended 2026-06-30 | −$43.46MTTM ended 2026-06-30 |
| PTCT | PTC THERAPEUTICS, INC. | $5.35B | $1.01BTTM ended 2026-06-30 | −$38.38MTTM ended 2026-06-30 |
| ERAS | Erasca, Inc. | $5.10B | — | −$287.22MTTM ended 2026-06-30 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | $4.94B | $2.04MTTM ended 2025-12-31 | −$192.25MTTM ended 2026-06-30 |
| MANE | Veradermics, Inc | $4.90B | — | −$92.68MTTM ended 2026-06-30 |
| EWTX | Edgewise Therapeutics, Inc. | $4.40B | — | −$197.22MTTM ended 2026-06-30 |
| INDV | Indivior Pharmaceuticals, Inc. | $4.18B | $1.33BTTM ended 2026-06-30 | $356.00MTTM ended 2026-06-30 |
| TNGX | Tango Therapeutics, Inc. | $4.12B | $53.81MTTM ended 2026-06-30 | −$123.72MTTM ended 2026-06-30 |
| IDYA | IDEAYA Biosciences, Inc. | $3.65B | $218.71MTTM ended 2025-12-31 | −$175.02MTTM ended 2026-06-30 |
| OGN | Organon & Co. | $3.60B | $6.13BTTM ended 2026-06-30 | $209.00MTTM ended 2026-06-30 |
| VKTX | Viking Therapeutics, Inc. | $3.56B | $0.00TTM ended 2026-06-30 | −$534.80MTTM ended 2026-06-30 |
| ACAD | ACADIA PHARMACEUTICALS INC | $3.43B | $1.14BTTM ended 2026-06-30 | $380.48MTTM ended 2026-06-30 |
| ELVN | Enliven Therapeutics, Inc. | $3.39B | — | −$105.93MTTM ended 2026-06-30 |
| RCUS | Arcus Biosciences, Inc. | $3.21B | $117.00MTTM ended 2026-06-30 | −$460.00MTTM ended 2026-06-30 |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.18B | $463.98MTTM ended 2026-06-30 | $28.52MTTM ended 2026-06-30 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.13B | $0.00TTM ended 2025-12-31 | −$152.09MTTM ended 2026-06-30 |
| DYN | Dyne Therapeutics, Inc. | $2.95B | — | −$519.40MTTM ended 2026-06-30 |
| PGEN | PRECIGEN, INC. | $2.94B | $85.72MTTM ended 2026-06-30 | −$157.71MTTM ended 2026-06-30 |
| NAMS | NewAmsterdam Pharma Co N.V. | $2.89B | $7.12MTTM ended 2026-06-30 | −$259.50MTTM ended 2026-06-30 |
| ATAI | AtaiBeckley Inc. | $2.73B | $4.47MTTM ended 2026-06-30 | −$668.19MTTM ended 2026-06-30 |
| MBX | MBX Biosciences, Inc. | $2.72B | — | −$104.29MTTM ended 2026-06-30 |
| LQDA | Liquidia Corp | $2.51B | $450.91MTTM ended 2026-06-30 | $138.61MTTM ended 2026-06-30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | $2.45B | $830.44MTTM ended 2026-06-30 | −$109.89MTTM ended 2026-06-30 |
| IRON | Disc Medicine, Inc. | $2.44B | — | −$245.89MTTM ended 2026-06-30 |
| NRIX | Nurix Therapeutics, Inc. | $2.42B | $36.77MTTM ended 2026-05-31 | −$341.35MTTM ended 2026-05-31 |
| IMNM | Immunome Inc. | $2.37B | $0.00TTM ended 2026-06-30 | −$254.32MTTM ended 2026-06-30 |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.30B | $959.90MTTM ended 2026-06-30 | $181.27MTTM ended 2026-06-30 |
| SLS | SELLAS Life Sciences Group, Inc. | $2.29B | — | −$32.46MTTM ended 2026-06-30 |
| SDGR | Schrodinger, Inc. | $2.28B | $259.04MTTM ended 2026-06-30 | −$54.34MTTM ended 2026-06-30 |
| VERA | Vera Therapeutics, Inc. | $2.23B | — | −$401.89MTTM ended 2026-06-30 |
| VRDN | Viridian Therapeutics, Inc.DE | $2.15B | $71.13MTTM ended 2026-06-30 | −$386.97MTTM ended 2026-06-30 |
| BHC | Bausch Health Companies Inc. | $2.14B | $10.85BTTM ended 2026-06-30 | −$1.10BTTM ended 2026-06-30 |
| PBH | Prestige Consumer Healthcare Inc. | $2.12B | $1.10BTTM ended 2026-06-30 | $172.01MTTM ended 2026-06-30 |
| MLYS | Mineralys Therapeutics, Inc. | $2.10B | — | −$349.58MTTM ended 2026-06-30 |
| TRVI | Trevi Therapeutics, Inc. | $2.02B | — | −$51.11MTTM ended 2026-06-30 |
| BHVN | Biohaven Ltd. | $1.98B | — | −$586.84MTTM ended 2026-06-30 |
| NUVB | Nuvation Bio Inc. | $1.95B | $169.90MTTM ended 2026-06-30 | −$149.83MTTM ended 2026-06-30 |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | $1.95B | $208.78MTTM ended 2026-06-30 | −$77.39MTTM ended 2026-06-30 |
| PRGO | PERRIGO Co plc | $1.95B | $4.14BTTM ended 2026-06-27 | −$1.73BTTM ended 2026-06-27 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | $1.94B | $98.34MTTM ended 2026-06-30 | −$411.29MTTM ended 2026-06-30 |
| BRVE | Braveheart Bio, Inc. | $1.93B | — | — |
| PVLA | PALVELLA THERAPEUTICS, INC. | $1.91B | — | −$61.70MTTM ended 2026-06-30 |
| SRPT | Sarepta Therapeutics, Inc. | $1.86B | $1.97BTTM ended 2026-06-30 | −$136.72MTTM ended 2026-06-30 |
| ZYME | Zymeworks Inc. | $1.84B | $37.13MTTM ended 2026-06-30 | −$149.99MTTM ended 2026-06-30 |
| XNCR | Xencor Inc | $1.84B | $104.97MTTM ended 2026-06-30 | −$163.32MTTM ended 2026-06-30 |
| ZBIO | Zenas BioPharma, Inc. | $1.82B | $1.00MTTM ended 2026-06-30 | −$484.38MTTM ended 2026-06-30 |
| SEPN | Septerna, Inc. | $1.78B | $98.88MTTM ended 2026-06-30 | −$24.24MTTM ended 2026-06-30 |
| XERS | Xeris Biopharma Holdings, Inc. | $1.69B | $335.41MTTM ended 2026-06-30 | −$17.16MTTM ended 2026-06-30 |
| STOK | Stoke Therapeutics, Inc. | $1.68B | $27.59MTTM ended 2026-06-30 | −$207.90MTTM ended 2026-06-30 |
| ANIP | ANI PHARMACEUTICALS INC | $1.68B | $978.38MTTM ended 2026-06-30 | $108.31MTTM ended 2026-06-30 |
| FBRX | Forte Biosciences, Inc. | $1.63B | — | −$87.94MTTM ended 2026-06-30 |
| SNDX | Syndax Pharmaceuticals Inc | $1.63B | $252.25MTTM ended 2026-06-30 | −$220.76MTTM ended 2026-06-30 |
| QURE | uniQure N.V. | $1.62B | $16.10MTTM ended 2025-12-31 | −$208.87MTTM ended 2026-03-31 |
| NKTR | NEKTAR THERAPEUTICS | $1.60B | $54.59MTTM ended 2026-06-30 | −$157.13MTTM ended 2026-06-30 |
| OCUL | OCULAR THERAPEUTIX, INC | $1.60B | $52.05MTTM ended 2026-06-30 | −$301.45MTTM ended 2026-06-30 |
| RAPP | Rapport Therapeutics, Inc. | $1.58B | — | −$137.16MTTM ended 2026-06-30 |
| ETON | Eton Pharmaceuticals, Inc. | $1.49B | $105.59MTTM ended 2026-06-30 | $12.69MTTM ended 2026-06-30 |
| INVA | Innoviva, Inc. | $1.48B | $440.00MTTM ended 2026-06-30 | $357.24MTTM ended 2026-06-30 |
| PAHC | PHIBRO ANIMAL HEALTH CORP | $1.46B | $1.52BTTM ended 2026-06-30 | $99.72MTTM ended 2026-06-30 |
| RARE | Ultragenyx Pharmaceutical Inc. | $1.45B | $717.00MTTM ended 2026-06-30 | −$586.00MTTM ended 2026-06-30 |
| KALV | KalVista Pharmaceuticals, Inc. | $1.44B | — | −$203.10MTTM ended 2025-07-31 |
| AVBP | ArriVent BioPharma, Inc. | $1.43B | — | −$163.74MTTM ended 2026-06-30 |
| ANAB | ANAPTYSBIO, INC | $1.42B | $232.39MTTM ended 2026-03-31 | −$26.79MTTM ended 2026-03-31 |
| OMER | OMEROS CORP | $1.34B | — | $124.83MTTM ended 2026-06-30 |
| ORIC | Oric Pharmaceuticals, Inc. | $1.30B | — | −$140.35MTTM ended 2026-06-30 |
| MNKD | MANNKIND CORP | $1.27B | $393.63MTTM ended 2026-06-30 | −$43.61MTTM ended 2026-06-30 |
| TYRA | Tyra Biosciences, Inc. | $1.25B | — | −$148.56MTTM ended 2026-06-30 |
| DMRA | Damora Therapeutics, Inc. | $1.25B | — | −$262.83MTTM ended 2026-06-30 |
| BCAX | Bicara Therapeutics Inc. | $1.20B | — | −$185.36MTTM ended 2026-06-30 |
| LBRX | LB PHARMACEUTICALS INC | $1.20B | — | −$85.69MTTM ended 2026-06-30 |
| OPK | OPKO HEALTH, INC. | $1.17B | $587.90MTTM ended 2026-06-30 | −$72.89MTTM ended 2026-06-30 |
| HROW | HARROW, INC. | $1.15B | $275.59MTTM ended 2026-06-30 | −$37.23MTTM ended 2026-06-30 |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.08B | $730.02MTTM ended 2026-06-30 | $78.55MTTM ended 2026-06-30 |
| JANX | Janux Therapeutics, Inc. | $1.04B | $24.00MTTM ended 2026-06-30 | −$102.59MTTM ended 2026-06-30 |
| SVRA | Savara Inc | $1.04B | — | −$139.31MTTM ended 2026-06-30 |
| PCRX | Pacira BioSciences, Inc. | $996.95M | $746.16MTTM ended 2026-06-30 | $14.64MTTM ended 2026-06-30 |
| ANRO | Alto Neuroscience, Inc. | $993.22M | — | −$84.24MTTM ended 2026-06-30 |
| MLTX | MoonLake Immunotherapeutics | $976.17M | — | −$263.67MTTM ended 2026-06-30 |
| KURA | Kura Oncology, Inc. | $947.43M | $77.22MTTM ended 2026-06-30 | −$296.77MTTM ended 2026-06-30 |
| ALMS | ALUMIS INC. | $933.23M | $7.40MTTM ended 2026-06-30 | −$438.96MTTM ended 2026-06-30 |
| CRVS | Corvus Pharmaceuticals, Inc. | $919.44M | — | −$54.13MTTM ended 2026-06-30 |
| ABUS | Arbutus Biopharma Corp | $902.19M | $181.72MTTM ended 2026-06-30 | $153.05MTTM ended 2026-06-30 |
| TBPH | Theravance Biopharma, Inc. | $884.18M | $104.31MTTM ended 2026-06-30 | $53.81MTTM ended 2026-06-30 |
| CYRX | Cryoport, Inc. | $879.27M | $186.45MTTM ended 2026-06-30 | −$37.39MTTM ended 2026-06-30 |
| RIGL | RIGEL PHARMACEUTICALS INC | $877.39M | $276.79MTTM ended 2026-06-30 | $321.91MTTM ended 2026-06-30 |
| JBIO | Jade Biosciences, Inc. | $875.74M | — | −$153.24MTTM ended 2026-06-30 |
| ARDX | ARDELYX, INC. | $842.25M | $450.89MTTM ended 2026-06-30 | −$55.70MTTM ended 2026-06-30 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | $809.82M | $41.47MTTM ended 2026-06-30 | −$61.12MTTM ended 2026-06-30 |
| AVTX | Avalo Therapeutics, Inc. | $801.77M | $59.00KTTM ended 2025-12-31 | −$100.33MTTM ended 2026-06-30 |
| ANNX | Annexon, Inc. | $781.07M | — | −$202.67MTTM ended 2026-06-30 |
| GYRE | GYRE THERAPEUTICS, INC. | $780.57M | $109.82MTTM ended 2026-06-30 | −$28.22MTTM ended 2026-06-30 |
| GERN | GERON CORP | $777.39M | — | −$67.61MTTM ended 2026-06-30 |
| DSGN | Design Therapeutics, Inc. | $766.00M | $0.00TTM ended 2026-06-30 | −$70.80MTTM ended 2026-06-30 |
| WVE | Wave Life Sciences Ltd. | $764.55M | $65.37MTTM ended 2026-06-30 | −$202.47MTTM ended 2026-06-30 |
| IMMX | Immix Biopharma, Inc. | $731.85M | — | −$39.92MTTM ended 2026-06-30 |
| SNSE | Sensei Biotherapeutics, Inc. | $730.51M | — | −$195.53MTTM ended 2026-06-30 |
| OLMA | Olema Pharmaceuticals, Inc. | $723.61M | — | −$204.57MTTM ended 2026-06-30 |
| VSTM | Verastem, Inc. | $715.45M | $87.53MTTM ended 2026-06-30 | −$202.70MTTM ended 2026-06-30 |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | $711.01M | $808.21MTTM ended 2026-06-30 | $47.91MTTM ended 2026-06-30 |
| STTK | Shattuck Labs, Inc. | $686.48M | $1.00MTTM ended 2026-06-30 | −$52.57MTTM ended 2026-06-30 |
| NVCT | Nuvectis Pharma, Inc. | $675.09M | — | −$27.85MTTM ended 2026-06-30 |
| ACRS | Aclaris Therapeutics, Inc. | $649.15M | $8.22MTTM ended 2026-06-30 | −$75.74MTTM ended 2026-06-30 |
| CLYM | Climb Bio, Inc. | $635.82M | — | −$57.62MTTM ended 2026-06-30 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $621.30M | $389.32MTTM ended 2026-06-30 | $129.87MTTM ended 2026-06-30 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | $604.53M | $136.07MTTM ended 2026-06-30 | $58.26MTTM ended 2026-06-30 |
| IBO | IMPACT BIOMEDICAL INC. | $585.47M | $35.00KTTM ended 2026-06-30 | $791.00KTTM ended 2026-06-30 |
| SGMT | Sagimet Biosciences Inc. | $582.43M | — | −$47.08MTTM ended 2026-06-30 |
| CRMD | CorMedix Inc. | $578.35M | $311.71MTTM ended 2025-12-31 | $187.17MTTM ended 2026-06-30 |
| CTMX | CytomX Therapeutics, Inc. | $573.08M | $18.30MTTM ended 2026-06-30 | −$79.65MTTM ended 2026-06-30 |
| PHAT | Phathom Pharmaceuticals, Inc. | $572.78M | $239.66MTTM ended 2026-06-30 | −$99.07MTTM ended 2026-06-30 |
| AQST | Aquestive Therapeutics, Inc. | $557.27M | $54.09MTTM ended 2026-06-30 | −$78.23MTTM ended 2026-06-30 |
| ALT | Altimmune, Inc. | $536.87M | $41.00KTTM ended 2025-12-31 | −$91.76MTTM ended 2026-06-30 |
| NGNE | Neurogene Inc. | $531.30M | $0.00TTM ended 2025-12-31 | −$111.11MTTM ended 2026-06-30 |
| CBIO | CRESCENT BIOPHARMA, INC. | $529.67M | $11.88MTTM ended 2026-06-30 | −$165.12MTTM ended 2026-06-30 |
| MNPR | Monopar Therapeutics | $523.35M | $0.00TTM ended 2025-12-31 | −$17.84MTTM ended 2026-06-30 |
| CAPR | CAPRICOR THERAPEUTICS, INC. | $519.76M | $0.00TTM ended 2025-12-31 | −$129.42MTTM ended 2026-06-30 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | $507.94M | $231.24MTTM ended 2026-06-30 | $26.72MTTM ended 2026-06-30 |
| EOLS | Evolus, Inc. | $507.93M | $316.49MTTM ended 2026-06-30 | −$34.33MTTM ended 2026-06-30 |
| CTNM | Contineum Therapeutics, Inc. | $488.70M | — | −$57.56MTTM ended 2026-06-30 |
| ARVN | ARVINAS, INC. | $485.82M | $262.60MTTM ended 2025-12-31 | $9.30MTTM ended 2026-06-30 |
| OVID | Ovid Therapeutics Inc. | $474.57M | $1.58MTTM ended 2026-06-30 | −$34.49MTTM ended 2026-06-30 |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | $467.89M | $72.30MTTM ended 2025-12-31 | −$42.00KTTM ended 2026-06-30 |
| DMAC | DiaMedica Therapeutics Inc. | $450.28M | — | −$37.54MTTM ended 2026-06-30 |
| MPLT | MapLight Therapeutics, Inc. | $446.62M | — | −$229.83MTTM ended 2026-06-30 |
| PRTA | PROTHENA CORP PUBLIC LTD CO | $438.42M | $54.53MTTM ended 2026-06-30 | −$43.99MTTM ended 2026-06-30 |
| SPRY | ARS Pharmaceuticals, Inc. | $409.72M | $116.93MTTM ended 2026-06-30 | −$215.43MTTM ended 2026-06-30 |
| AVIR | Atea Pharmaceuticals, Inc. | $409.04M | — | −$165.29MTTM ended 2026-06-30 |
| TTRX | Turn Therapeutics Inc. | $396.48M | — | −$8.45MTTM ended 2026-06-30 |
| RZLT | Rezolute, Inc. | $393.66M | — | −$77.59MTTM ended 2026-06-30 |
| RLMD | RELMADA THERAPEUTICS, INC. | $390.41M | — | −$61.93MTTM ended 2026-06-30 |
| GALT | GALECTIN THERAPEUTICS INC | $379.19M | — | −$27.84MTTM ended 2026-06-30 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $375.47M | $29.37MTTM ended 2026-06-30 | −$93.28MTTM ended 2026-06-30 |
| IRD | Opus Genetics, Inc. | $375.21M | $9.86MTTM ended 2026-06-30 | −$107.61MTTM ended 2026-06-30 |
| ENTA | ENANTA PHARMACEUTICALS INC | $373.97M | $65.26MTTM ended 2026-06-30 | −$63.23MTTM ended 2026-06-30 |
| BNTC | Benitec Biopharma Inc. | $334.18M | — | −$45.55MTTM ended 2026-06-30 |
| EBS | Emergent BioSolutions Inc. | $326.61M | $770.20MTTM ended 2026-06-30 | −$176.80MTTM ended 2026-06-30 |
| LRMR | Larimar Therapeutics, Inc. | $317.88M | — | −$172.60MTTM ended 2026-06-30 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $315.89M | — | −$182.11MTTM ended 2026-06-30 |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $314.67M | — | −$877.00KTTM ended 2026-06-30 |
| BIOA | BioAge Labs, Inc. | $312.56M | $10.36MTTM ended 2026-06-30 | −$94.46MTTM ended 2026-06-30 |
| CATX | Perspective Therapeutics, Inc. | $310.49M | — | −$116.43MTTM ended 2026-06-30 |
| PRLD | Prelude Therapeutics Inc | $302.46M | $22.42MTTM ended 2026-06-30 | −$60.49MTTM ended 2026-06-30 |
| VNDA | Vanda Pharmaceuticals Inc. | $290.83M | $215.72MTTM ended 2026-06-30 | −$274.85MTTM ended 2026-06-30 |
| ABEO | ABEONA THERAPEUTICS INC. | $286.49M | $25.52MTTM ended 2026-06-30 | −$62.89MTTM ended 2026-06-30 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | $284.32M | $0.00TTM ended 2026-06-30 | −$17.25MTTM ended 2026-06-30 |
| INDP | Indaptus Therapeutics, Inc. | $282.47M | — | −$15.42MTTM ended 2026-06-30 |
| FULC | Fulcrum Therapeutics, Inc. | $280.77M | $0.00TTM ended 2025-12-31 | −$85.00MTTM ended 2026-06-30 |
| GTBP | GT Biopharma, Inc. | $279.68M | — | −$4.76MTTM ended 2026-06-30 |
| UPB | Upstream Bio, Inc. | $276.05M | $3.16MTTM ended 2026-06-30 | −$156.50MTTM ended 2026-06-30 |
| EVMN | Evommune, Inc. | $261.67M | $10.00MTTM ended 2026-06-30 | −$94.67MTTM ended 2026-06-30 |
| IMRX | Immuneering Corp | $260.73M | — | −$57.28MTTM ended 2026-06-30 |
| GLSI | Greenwich LifeSciences, Inc. | $254.67M | — | −$22.47MTTM ended 2026-06-30 |
| LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | $247.18M | $128.87MTTM ended 2025-05-25 | −$38.72MTTM ended 2025-05-25 |
| QTTB | Q32 Bio Inc. | $245.60M | $53.74MTTM ended 2025-12-31 | $33.79MTTM ended 2026-06-30 |
| AKBA | Akebia Therapeutics, Inc. | $241.36M | $219.06MTTM ended 2026-06-30 | −$29.67MTTM ended 2026-06-30 |
| CAMP | Camp4 Therapeutics Corp | $240.97M | $4.22MTTM ended 2026-06-30 | −$107.24MTTM ended 2026-06-30 |
| SIGA | SIGA TECHNOLOGIES INC | $240.70M | $53.66MTTM ended 2026-06-30 | −$2.79MTTM ended 2026-06-30 |
| LYEL | Lyell Immunopharma, Inc. | $230.59M | $27.00KTTM ended 2026-06-30 | −$248.48MTTM ended 2026-06-30 |
| SION | Sionna Therapeutics, Inc. | $230.58M | — | −$97.38MTTM ended 2026-06-30 |
| MGNX | MACROGENICS INC | $229.32M | $175.14MTTM ended 2026-06-30 | −$14.59MTTM ended 2026-06-30 |
| KROS | Keros Therapeutics, Inc. | $223.25M | $15.01MTTM ended 2026-06-30 | −$83.16MTTM ended 2026-06-30 |
| NATR | NATURES SUNSHINE PRODUCTS INC | $221.53M | $492.02MTTM ended 2026-06-30 | $18.10MTTM ended 2026-06-30 |
| TRDA | Entrada Therapeutics, Inc. | $221.16M | $4.69MTTM ended 2026-06-30 | −$165.78MTTM ended 2026-06-30 |
| RNAC | Cartesian Therapeutics, Inc. | $218.44M | $1.48MTTM ended 2026-06-30 | −$151.89MTTM ended 2026-06-30 |
| WHWK | Whitehawk Therapeutics, Inc. | $214.35M | $0.00TTM ended 2026-06-30 | −$79.83MTTM ended 2026-06-30 |
| ANTX | AN2 Therapeutics, Inc. | $212.08M | — | −$36.27MTTM ended 2026-06-30 |
| ELDN | Eledon Pharmaceuticals, Inc. | $197.87M | — | −$98.56MTTM ended 2026-06-30 |
| DERM | Journey Medical Corp | $189.67M | $68.18MTTM ended 2026-06-30 | −$6.10MTTM ended 2026-06-30 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $186.71M | $0.00TTM ended 2025-12-31 | −$139.54MTTM ended 2026-06-30 |
| ORMP | ORAMED PHARMACEUTICALS INC. | $186.36M | $2.00MTTM ended 2025-12-31 | $174.87MTTM ended 2026-06-30 |
| SDEV | Stablecoin Development Corp | $185.25M | $10.30MTTM ended 2025-09-30 | −$125.19MTTM ended 2026-06-30 |
| CUE | Cue Biopharma, Inc. | $183.43M | $37.66MTTM ended 2026-06-30 | −$164.11MTTM ended 2026-06-30 |
| NKTX | Nkarta, Inc. | $183.36M | $0.00TTM ended 2025-12-31 | −$117.32MTTM ended 2026-06-30 |
| PYXS | Pyxis Oncology, Inc. | $182.66M | $13.86MTTM ended 2025-12-31 | −$88.73MTTM ended 2026-06-30 |
| ORGO | Organogenesis Holdings Inc. | $180.14M | $457.45MTTM ended 2026-06-30 | −$84.16MTTM ended 2026-06-30 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | $179.76M | — | −$80.89MTTM ended 2026-06-30 |
| CNTN | Canton Strategic Holdings, Inc. | $174.10M | — | −$98.12MTTM ended 2026-06-30 |
| FHTX | Foghorn Therapeutics Inc. | $173.41M | $36.74MTTM ended 2026-06-30 | −$64.58MTTM ended 2026-06-30 |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $158.30M | $29.10MTTM ended 2026-06-30 | −$159.67MTTM ended 2026-06-30 |
| CURX | Curanex Pharmaceuticals Inc | $155.88M | — | −$10.47MTTM ended 2026-06-30 |
| NERV | Minerva Neurosciences, Inc. | $154.22M | — | −$394.35MTTM ended 2026-06-30 |
| PEPG | PepGen Inc. | $153.06M | — | −$71.94MTTM ended 2026-06-30 |
| ASRT | Assertio Holdings, Inc. | $151.86M | $102.16MTTM ended 2026-03-31 | −$35.69MTTM ended 2026-03-31 |
| CYCN | Cyclerion Therapeutics, Inc. | $146.06M | $1.90MTTM ended 2026-06-30 | −$6.71MTTM ended 2026-06-30 |
| KRRO | Korro Bio, Inc. | $142.99M | $2.38MTTM ended 2026-06-30 | −$106.64MTTM ended 2026-06-30 |
| ADCT | ADC Therapeutics SA | $137.88M | $79.58MTTM ended 2026-06-30 | −$96.91MTTM ended 2026-06-30 |
| SPRB | SPRUCE BIOSCIENCES, INC. | $128.67M | $0.00TTM ended 2025-12-31 | −$51.35MTTM ended 2026-06-30 |
| UNCY | Unicycive Therapeutics, Inc. | $126.74M | — | −$35.22MTTM ended 2026-06-30 |
| HURA | TuHURA Biosciences, Inc./NV | $126.18M | $0.00TTM ended 2026-03-31 | −$30.62MTTM ended 2026-06-30 |
| VTVT | vTv Therapeutics Inc. | $125.94M | $36.84MTTM ended 2026-06-30 | −$4.76MTTM ended 2026-06-30 |
| INO | INOVIO PHARMACEUTICALS, INC. | $125.11M | $0.00TTM ended 2026-06-30 | −$67.43MTTM ended 2026-06-30 |
| NRXP | NRX Pharmaceuticals, Inc. | $123.39M | $3.39MTTM ended 2026-06-30 | −$23.48MTTM ended 2026-06-30 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $122.62M | — | −$101.90MTTM ended 2026-06-30 |
| IMUX | IMMUNIC, INC. | $117.89M | — | −$111.57MTTM ended 2026-06-30 |
| AARD | Aardvark Therapeutics, Inc. | $115.33M | $0.00TTM ended 2026-06-30 | −$69.89MTTM ended 2026-06-30 |
| GNLX | GENELUX Corp | $114.02M | $8.00KTTM ended 2025-12-31 | −$35.60MTTM ended 2026-06-30 |
| QUCY | Quantum Cyber N.V. | $113.49M | $537.08KTTM ended 2025-12-31 | −$23.83MTTM ended 2026-06-30 |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | $112.52M | $39.90MTTM ended 2026-06-30 | −$10.92MTTM ended 2026-06-30 |
| RANI | Rani Therapeutics Holdings, Inc. | $110.96M | $4.88MTTM ended 2026-06-30 | −$30.14MTTM ended 2026-06-30 |
| COYA | Coya Therapeutics, Inc. | $110.96M | $8.02MTTM ended 2026-06-30 | −$21.67MTTM ended 2026-06-30 |
| OKUR | OnKure Therapeutics, Inc. | $102.86M | — | −$58.70MTTM ended 2026-06-30 |
| PLYX | Polaryx Therapeutics, Inc. | $100.69M | — | −$6.85MTTM ended 2026-06-30 |
| EQ | Equillium, Inc. | $97.65M | — | −$18.01MTTM ended 2026-06-30 |
| ANIX | Anixa Biosciences Inc | $96.30M | — | −$10.38MTTM ended 2026-07-31 |
| BMEA | Biomea Fusion, Inc. | $94.23M | — | −$32.54MTTM ended 2026-06-30 |
| PMVP | PMV Pharmaceuticals, Inc. | $93.55M | — | −$75.22MTTM ended 2026-06-30 |
| CTOR | CITIUS ONCOLOGY, INC. | $91.12M | — | −$46.06MTTM ended 2026-06-30 |
| RLYB | Rallybio Corp | $89.00M | $646.00KTTM ended 2026-06-30 | $45.55MTTM ended 2026-06-30 |
| ACRV | Acrivon Therapeutics, Inc. | $86.14M | — | −$74.22MTTM ended 2026-06-30 |
| LGVN | Longeveron Inc. | $82.57M | $1.19MTTM ended 2026-06-30 | −$23.47MTTM ended 2026-06-30 |
| ONCY | ONCOLYTICS BIOTECH INC | $81.61M | — | −$37.46MTTM ended 2026-06-30 |
| TELO | Telomir Pharmaceuticals, Inc. | $80.47M | — | −$5.88MTTM ended 2026-06-30 |
| MNOV | MEDICINOVA INC | $80.23M | $920.48KTTM ended 2026-06-30 | −$10.75MTTM ended 2026-06-30 |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | $79.37M | $0.00TTM ended 2026-06-30 | −$47.20MTTM ended 2026-06-30 |
| LFVN | Lifevantage Corp | $78.17M | $182.59MTTM ended 2026-06-30 | $5.07MTTM ended 2026-06-30 |
| RFL | Rafael Holdings, Inc. | $78.00M | $980.00KTTM ended 2026-04-30 | −$32.55MTTM ended 2026-04-30 |
| ALDX | Aldeyra Therapeutics, Inc. | $77.82M | — | −$23.05MTTM ended 2026-06-30 |
| VRCA | Verrica Pharmaceuticals Inc. | $77.56M | $30.32MTTM ended 2026-06-30 | −$31.18MTTM ended 2026-06-30 |
| GANX | Gain Therapeutics, Inc. | $75.07M | — | −$20.11MTTM ended 2026-06-30 |
| OSTX | OS Therapies Inc | $74.26M | — | −$39.37MTTM ended 2026-06-30 |
| RNTX | Rein Therapeutics, Inc. | $73.50M | $0.00TTM ended 2026-06-30 | −$49.76MTTM ended 2026-06-30 |
| SPRO | Spero Therapeutics, Inc. | $73.38M | $47.00MTTM ended 2026-06-30 | $7.38MTTM ended 2026-06-30 |
| TENX | TENAX THERAPEUTICS, INC. | $72.23M | $0.00TTM ended 2026-06-30 | −$64.86MTTM ended 2026-06-30 |
| IBIO | iBio, Inc. | $71.38M | $100.00KTTM ended 2026-06-30 | −$33.04MTTM ended 2026-06-30 |
| MAIA | MAIA Biotechnology, Inc. | $71.17M | — | −$26.85MTTM ended 2026-06-30 |
| RNXT | RenovoRx, Inc. | $69.95M | $1.98MTTM ended 2026-06-30 | −$12.29MTTM ended 2026-06-30 |
| CING | Cingulate Inc. | $69.07M | — | −$28.80MTTM ended 2026-06-30 |
| FBIO | Fortress Biotech, Inc. | $69.04M | $68.47MTTM ended 2026-06-30 | $111.82MTTM ended 2026-06-30 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | $68.35M | $151.18MTTM ended 2026-06-30 | −$34.05MTTM ended 2026-06-30 |
| XBIT | XBiotech Inc. | $67.07M | — | −$45.13MTTM ended 2026-06-30 |
| GOSS | Gossamer Bio, Inc. | $66.79M | $53.29MTTM ended 2026-06-30 | −$125.22MTTM ended 2026-06-30 |
| PLRX | PLIANT THERAPEUTICS, INC. | $65.02M | $0.00TTM ended 2025-12-31 | −$92.29MTTM ended 2026-06-30 |
| VYNE | VYNE Therapeutics Inc. | $63.01M | $482.00KTTM ended 2026-06-30 | −$18.71MTTM ended 2026-06-30 |
| ACET | Adicet Bio, Inc. | $62.16M | — | −$98.97MTTM ended 2026-06-30 |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $62.15M | — | −$8.86MTTM ended 2026-06-30 |
| CNTB | Connect Biopharma Holdings Ltd | $61.71M | $2.95MTTM ended 2026-06-30 | −$68.99MTTM ended 2026-06-30 |
| BOLD | Boundless Bio, Inc. | $58.92M | — | −$64.01MTTM ended 2026-06-30 |
| TLPH | TALPHERA, INC. | $58.13M | $1.00KTTM ended 2026-06-30 | −$15.08MTTM ended 2026-06-30 |
| HYPD | HYPERION DEFI, INC. | $56.87M | $1.40MTTM ended 2026-06-30 | $6.65MTTM ended 2026-06-30 |
| SKYE | Skye Bioscience, Inc. | $56.67M | — | −$50.49MTTM ended 2026-06-30 |
| CALC | CalciMedica, Inc. | $56.33M | — | −$21.24MTTM ended 2026-06-30 |
| SCYX | SCYNEXIS INC | $53.43M | $19.22MTTM ended 2026-06-30 | −$10.23MTTM ended 2026-06-30 |
| CLNN | Clene Inc. | $51.65M | $197.00KTTM ended 2026-06-30 | −$39.52MTTM ended 2026-06-30 |
| XLO | Xilio Therapeutics, Inc. | $51.52M | $64.09MTTM ended 2026-06-30 | −$21.83MTTM ended 2026-06-30 |
| ELTX | Elicio Therapeutics, Inc. | $50.46M | — | −$37.84MTTM ended 2026-06-30 |
| LNAI | Lunai Bioworks Inc. | $50.05M | — | −$128.28MTTM ended 2026-03-31 |
| ANVS | Annovis Bio, Inc. | $49.85M | $0.00TTM ended 2026-06-30 | −$49.52MTTM ended 2026-06-30 |
| SER | Serina Therapeutics, Inc. | $49.53M | $0.00TTM ended 2026-06-30 | −$21.18MTTM ended 2026-06-30 |
| DWTX | Dogwood Therapeutics, Inc. | $48.61M | — | −$36.04MTTM ended 2026-06-30 |
| FLNA | FILANA THERAPEUTICS, INC. | $46.86M | — | −$77.90MTTM ended 2026-03-31 |
| CELU | Celularity Inc | $44.78M | $18.97MTTM ended 2026-03-31 | −$71.09MTTM ended 2026-03-31 |
| CRVO | CervoMed Inc. | $44.30M | $331.30KTTM ended 2026-06-30 | −$30.35MTTM ended 2026-06-30 |
| VERU | VERU INC. | $43.31M | — | −$13.61MTTM ended 2026-06-30 |
| GRCE | Grace Therapeutics, Inc. | $42.91M | — | −$20.22MTTM ended 2026-06-30 |
| HOWL | Werewolf Therapeutics, Inc. | $42.86M | — | −$34.61MTTM ended 2026-06-30 |
| LITS | Lite Strategy, Inc. | $41.96M | $0.00TTM ended 2025-06-30 | −$71.15MTTM ended 2026-06-30 |
| IXHL | Incannex Healthcare Inc. | $40.77M | $0.00TTM ended 2026-06-30 | −$19.30MTTM ended 2026-06-30 |
| PDSB | PDS Biotechnology Corp | $39.52M | — | −$33.67MTTM ended 2026-06-30 |
| KAPA | Kairos Pharma, LTD. | $36.97M | — | −$5.80MTTM ended 2026-06-30 |
| ATNM | Actinium Pharmaceuticals, Inc. | $36.16M | $90.00KTTM ended 2025-12-31 | $11.31MTTM ended 2026-06-30 |
| RMTI | ROCKWELL MEDICAL, INC. | $34.54M | $69.39MTTM ended 2026-06-30 | −$5.08MTTM ended 2026-06-30 |
| BYSI | BeyondSpring Inc. | $33.47M | $0.00TTM ended 2026-06-30 | −$6.68MTTM ended 2026-06-30 |
| NNVC | NANOVIRICIDES, INC. | $32.16M | $0.00TTM ended 2026-06-30 | −$8.22MTTM ended 2026-06-30 |
| MIRA | MIRA PHARMACEUTICALS, INC. | $30.38M | — | −$9.48MTTM ended 2026-06-30 |
| MCRB | Seres Therapeutics, Inc. | $29.13M | $1.88MTTM ended 2026-06-30 | −$22.46MTTM ended 2026-06-30 |
| CNTX | Context Therapeutics Inc. | $28.85M | — | −$45.96MTTM ended 2026-06-30 |
| IGC | IGC Pharma, Inc. | $27.91M | $1.11MTTM ended 2025-09-30 | −$6.45MTTM ended 2025-09-30 |
| ABVC | ABVC BIOPHARMA, INC. | $27.19M | $296.00KTTM ended 2025-12-31 | −$7.11MTTM ended 2026-06-30 |
| KYNB | KYNTRA BIO, INC. | $26.32M | $4.62MTTM ended 2026-06-30 | $183.19MTTM ended 2026-06-30 |
| RNAZ | Transcode Therapeutics, Inc. | $26.16M | — | −$42.83MTTM ended 2026-06-30 |
| ELAB | PMGC Holdings Inc. | $26.11M | $590.08KTTM ended 2025-12-31 | −$13.49MTTM ended 2026-06-30 |
| GRDX | GridAI Technologies Corp. | $24.53M | $36.25KTTM ended 2025-12-31 | −$20.77MTTM ended 2026-06-30 |
| TXMD | TherapeuticsMD, Inc. | $23.50M | $3.27MTTM ended 2026-06-30 | −$217.00KTTM ended 2026-06-30 |
| AYTU | AYTU BIOPHARMA, INC | $22.71M | $57.57MTTM ended 2026-06-30 | −$14.25MTTM ended 2026-06-30 |
| NXTC | NextCure, Inc. | $22.70M | — | −$42.75MTTM ended 2026-06-30 |
| ATOS | ATOSSA THERAPEUTICS, INC. | $22.65M | — | −$37.71MTTM ended 2026-06-30 |
| COCP | Cocrystal Pharma, Inc. | $21.96M | — | −$9.94MTTM ended 2026-06-30 |
| ACTU | ACTUATE THERAPEUTICS, INC. | $21.35M | — | −$20.45MTTM ended 2026-06-30 |
| JAGX | Jaguar Health, Inc. | $20.41M | $27.82MTTM ended 2026-06-30 | −$36.92MTTM ended 2026-06-30 |
| KPTI | Karyopharm Therapeutics Inc. | $19.66M | $146.62MTTM ended 2026-06-30 | −$224.74MTTM ended 2026-06-30 |
| NEUP | Neuphoria Therapeutics Inc. | $18.99M | $1.17MTTM ended 2026-06-30 | −$13.45MTTM ended 2026-06-30 |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $18.82M | — | −$10.26MTTM ended 2026-06-30 |
| CLRB | Cellectar Biosciences, Inc. | $17.68M | — | −$22.32MTTM ended 2026-06-30 |
| ARTL | ARTELO BIOSCIENCES, INC. | $17.60M | — | −$12.67MTTM ended 2026-06-30 |
| MRKR | Marker Therapeutics, Inc. | $17.51M | $3.95MTTM ended 2026-03-31 | −$8.71MTTM ended 2026-06-30 |
| RKTO | Rocket One Inc. | $17.20M | — | −$13.32MTTM ended 2026-06-30 |
| LPCN | Lipocine Inc. | $17.07M | $1.57MTTM ended 2026-06-30 | −$11.85MTTM ended 2026-06-30 |
| ALLR | Allarity Therapeutics, Inc. | $16.55M | $345.00KTTM ended 2026-06-30 | −$12.33MTTM ended 2026-06-30 |
| TVRD | Tvardi Therapeutics, Inc. | $16.54M | — | −$26.06MTTM ended 2026-06-30 |
| KTTA | Pasithea Therapeutics Corp. | $16.34M | — | −$21.29MTTM ended 2026-06-30 |
| PTN | PALATIN TECHNOLOGIES INC | $16.14M | $13.19MTTM ended 2026-06-30 | −$8.38MTTM ended 2026-06-30 |
| BFRI | Biofrontera Inc. | $15.45M | $46.17MTTM ended 2026-06-30 | −$6.37MTTM ended 2026-06-30 |
| CTXR | Citius Pharmaceuticals, Inc. | $14.82M | — | −$58.17MTTM ended 2026-06-30 |
| AEON | AEON Biopharma, Inc. | $14.47M | — | −$54.62MTTM ended 2026-06-30 |
| HIND | Vyome Holdings, Inc | $13.48M | $129.72KTTM ended 2026-06-30 | −$11.31MTTM ended 2026-06-30 |
| LSTA | LISATA THERAPEUTICS, INC. | $13.43M | $100.00KTTM ended 2026-06-30 | −$14.62MTTM ended 2026-06-30 |
| DARE | Dare Bioscience, Inc. | $13.01M | $1.37MTTM ended 2026-06-30 | −$10.99MTTM ended 2026-06-30 |
| LTRN | Lantern Pharma Inc. | $12.78M | — | −$18.65MTTM ended 2026-06-30 |
| VTGN | Vistagen Therapeutics, Inc. | $12.43M | $2.50MTTM ended 2026-06-30 | −$67.62MTTM ended 2026-06-30 |
| BFRG | BullFrog AI Holdings, Inc. | $11.64M | $298.80KTTM ended 2026-06-30 | −$6.00MTTM ended 2026-06-30 |
| PHIO | Phio Pharmaceuticals Corp. | $11.62M | — | −$12.90MTTM ended 2026-06-30 |
| TPST | Tempest Therapeutics, Inc. | $11.56M | — | −$40.47MTTM ended 2026-06-30 |
| KPRX | KIORA PHARMACEUTICALS INC | $11.41M | $0.00TTM ended 2025-12-31 | −$10.99MTTM ended 2026-06-30 |
| ASBP | Aspire Biopharma Holdings, Inc. | $11.39M | $6.20KTTM ended 2025-12-31 | −$11.05MTTM ended 2026-06-30 |
| BIVI | BIOVIE INC. | $11.09M | — | −$22.07MTTM ended 2026-06-30 |
| ADIL | ADIAL PHARMACEUTICALS, INC. | $10.84M | — | −$57.80MTTM ended 2026-06-30 |
| TOVX | Theriva Biologics, Inc. | $10.56M | — | −$11.62MTTM ended 2026-06-30 |
| MTVA | MetaVia Inc. | $10.15M | — | −$14.45MTTM ended 2026-06-30 |
| MDCX | Medicus Pharma Ltd. | $9.92M | — | −$56.66MTTM ended 2026-06-30 |
| MBRX | Moleculin Biotech, Inc. | $9.82M | $0.00TTM ended 2026-06-30 | −$30.33MTTM ended 2026-06-30 |
| APRE | Aprea Therapeutics, Inc. | $9.12M | — | −$12.31MTTM ended 2026-06-30 |
| TRAW | Traws Pharma, Inc. | $8.45M | $2.79MTTM ended 2025-12-31 | −$21.57MTTM ended 2026-06-30 |
| KALA | KALA BIO, Inc. | $8.10M | $0.00TTM ended 2025-12-31 | −$10.08MTTM ended 2026-06-30 |
| FBLG | FibroBiologics, Inc. | $8.02M | — | −$18.14MTTM ended 2026-06-30 |
| SNGX | SOLIGENIX, INC. | $7.84M | — | −$10.24MTTM ended 2026-06-30 |
| AZTR | Azitra, Inc. | $7.82M | $0.00TTM ended 2025-12-31 | −$12.27MTTM ended 2026-06-30 |
| ENSC | Ensysce Biosciences, Inc. | $7.78M | $4.50MTTM ended 2026-06-30 | −$12.62MTTM ended 2026-06-30 |
| XCUR | EXICURE, INC. | $7.72M | $0.00TTM ended 2026-06-30 | −$8.28MTTM ended 2026-06-30 |
| CNSP | CNS Pharmaceuticals, Inc. | $7.66M | — | −$16.70MTTM ended 2026-06-30 |
| IMNN | Imunon, Inc. | $7.41M | — | −$14.72MTTM ended 2026-06-30 |
| SCNX | Scienture Holdings, Inc. | $7.27M | $821.32KTTM ended 2026-06-30 | −$37.95MTTM ended 2026-06-30 |
| BOLT | Bolt Biotherapeutics, Inc. | $6.76M | $4.70MTTM ended 2026-06-30 | −$28.74MTTM ended 2026-06-30 |
| ACXP | Acurx Pharmaceuticals, Inc. | $6.64M | — | −$7.51MTTM ended 2026-06-30 |
| ENVB | Enveric Biosciences, Inc. | $6.53M | — | −$8.73MTTM ended 2026-06-30 |
| ALZN | Alzamend Neuro, Inc. | $6.35M | — | −$9.10MTTM ended 2026-07-31 |
| APUS | Apimeds Pharmaceuticals US, Inc. | $6.19M | — | −$58.17MTTM ended 2026-06-30 |
| BGMS | Bio Green Med Solution, Inc. | $5.96M | $747.00KTTM ended 2025-12-31 | −$2.20MTTM ended 2026-06-30 |
| PULM | Pulmatrix, Inc. | $5.62M | — | −$4.01MTTM ended 2026-06-30 |
| XBIO | Xenetic Biosciences, Inc. | $5.25M | $3.26MTTM ended 2026-06-30 | −$2.48MTTM ended 2026-06-30 |
| LEXX | Lexaria Bioscience Corp. | $5.11M | $194.00KTTM ended 2026-05-31 | −$7.73MTTM ended 2026-05-31 |
| ERNA | Ernexa Therapeutics Inc. | $4.83M | — | −$12.26MTTM ended 2026-06-30 |
| PCSA | Processa Pharmaceuticals, Inc. | $4.53M | — | −$13.44MTTM ended 2026-06-30 |
| DRMA | Dermata Therapeutics, Inc. | $4.46M | — | −$8.37MTTM ended 2026-06-30 |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | $4.40M | $1.11MTTM ended 2026-06-30 | −$8.11MTTM ended 2026-06-30 |
| GRI | GRI Bio, Inc. | $4.28M | — | −$9.66MTTM ended 2026-06-30 |
| MBIO | MUSTANG BIO, INC. | $3.54M | — | −$3.03MTTM ended 2026-06-30 |
| CVKD | Cadrenal Therapeutics, Inc. | $3.46M | — | −$11.54MTTM ended 2026-06-30 |
| REVB | REVELATION BIOSCIENCES, INC. | $3.19M | — | −$10.75MTTM ended 2026-06-30 |
| APVO | Aptevo Therapeutics Inc. | $3.17M | — | −$26.41MTTM ended 2026-06-30 |
| HCWB | HCW Biologics Inc. | $3.10M | $6.72MTTM ended 2026-06-30 | −$5.58MTTM ended 2026-06-30 |
| ONCO | Onconetix, Inc. | $2.94M | $645.82KTTM ended 2026-06-30 | −$10.20MTTM ended 2026-06-30 |
| SBFM | Sunshine Biopharma Inc. | $2.67M | $35.35MTTM ended 2026-06-30 | −$5.83MTTM ended 2026-06-30 |
| SILO | Silo Pharma, Inc. | $2.38M | $54.08KTTM ended 2026-06-30 | −$4.47MTTM ended 2026-06-30 |
| GOVX | GeoVax Labs, Inc. | $2.37M | $0.00TTM ended 2026-06-30 | −$20.43MTTM ended 2026-06-30 |
| MTNB | Matinas BioPharma Holdings, Inc. | $2.37M | — | −$6.69MTTM ended 2026-06-30 |
| TCRT | Alaunos Therapeutics, Inc. | $2.34M | $3.00KTTM ended 2026-06-30 | −$4.01MTTM ended 2026-06-30 |
| OGEN | ORAGENICS INC | $2.17M | — | −$10.08MTTM ended 2026-06-30 |
| GNPX | Genprex, Inc. | $2.10M | — | −$16.50MTTM ended 2026-06-30 |
| NXTS | Nexentis Technologies Inc. | $2.08M | $209.00KTTM ended 2025-09-30 | −$16.03MTTM ended 2026-06-30 |
| JUNS | JUPITER NEUROSCIENCES, INC. | $1.93M | $40.45KTTM ended 2026-03-31 | −$9.20MTTM ended 2026-06-30 |
| BTAI | BioXcel Therapeutics, Inc. | $1.41M | $742.00KTTM ended 2026-06-30 | −$70.86MTTM ended 2026-06-30 |
| DCOY | Decoy Therapeutics Inc. | $1.22M | — | −$14.45MTTM ended 2026-06-30 |
| CDT | CDT Equity Inc. | $39.33K | — | −$37.15MTTM ended 2026-06-30 |
| ADTX | Aditxt, Inc. | $2.45K | $14.34KTTM ended 2026-03-31 | −$53.34MTTM ended 2026-03-31 |
| CPRX | CATALYST PHARMACEUTICALS, INC. | — | $596.96MTTM ended 2026-03-31 | $221.32MTTM ended 2026-03-31 |
| ESPR | Esperion Therapeutics, Inc. | — | $418.24MTTM ended 2026-03-31 | −$7.42MTTM ended 2026-03-31 |
| NUVL | Nuvalent, Inc. | — | — | −$450.07MTTM ended 2026-03-31 |
| XOMA | XOMA Royalty Corp | — | $48.55MTTM ended 2026-03-31 | $33.81MTTM ended 2026-03-31 |
No matching companies.